Physiomics Plc (PYC) - Total Assets
Based on the latest financial reports, Physiomics Plc (PYC) holds total assets worth GBX558.00K GBX (≈ $67.89 USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Physiomics Plc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Physiomics Plc - Total Assets Trend (2001–2025)
This chart illustrates how Physiomics Plc's total assets have evolved over time, based on quarterly financial data. Explore Physiomics Plc (PYC) long-term investment share to see how much of total assets are deployed in long-term investments.
Physiomics Plc - Asset Composition Analysis
Current Asset Composition (June 2025)
Physiomics Plc's total assets of GBX558.00K consist of 98.2% current assets and 1.8% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 51.7% |
| Accounts Receivable | GBX363.28K | 40.7% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX3.28K | 0.4% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Physiomics Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Physiomics Plc (PYC) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Physiomics Plc's current assets represent 98.2% of total assets in 2025, an increase from 52.5% in 2001.
- Cash Position: Cash and equivalents constituted 51.7% of total assets in 2025, up from 34.5% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 46.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 40.7% of total assets.
Physiomics Plc Competitors by Total Assets
Key competitors of Physiomics Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $8.59 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $763.95 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
China | CN¥4.48 Billion |
|
Novavax Inc
NASDAQ:NVAX
|
USA | $1.04 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
Physiomics Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.30 | 4.77 | 11.35 |
| Quick Ratio | 3.30 | 4.77 | 11.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX380.00K | GBX400.00K | GBX1.26 Million |
Physiomics Plc - Advanced Valuation Insights
This section examines the relationship between Physiomics Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.34 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 111.1% |
| Total Assets | GBX892.03K |
| Market Capitalization | $28.95K USD |
Valuation Analysis
Below Book Valuation: The market values Physiomics Plc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Physiomics Plc's assets grew by 111.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Physiomics Plc (2001–2025)
The table below shows the annual total assets of Physiomics Plc from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX892.03K ≈ $108.53 |
+111.08% |
| 2024-06-30 | GBX422.60K ≈ $51.42 |
-37.34% |
| 2023-06-30 | GBX674.39K ≈ $82.05 |
-39.54% |
| 2022-06-30 | GBX1.12 Million ≈ $135.71 |
-15.71% |
| 2021-06-30 | GBX1.32 Million ≈ $161.01 |
-8.52% |
| 2020-06-30 | GBX1.45 Million ≈ $176.00 |
+108.34% |
| 2019-06-30 | GBX694.29K ≈ $84.47 |
-15.15% |
| 2018-06-30 | GBX818.23K ≈ $99.56 |
+97.08% |
| 2017-06-30 | GBX415.18K ≈ $50.51 |
+36.88% |
| 2016-06-30 | GBX303.31K ≈ $36.90 |
-19.94% |
| 2015-06-30 | GBX378.87K ≈ $46.10 |
+55.15% |
| 2014-06-30 | GBX244.19K ≈ $29.71 |
-35.82% |
| 2013-06-30 | GBX380.47K ≈ $46.29 |
-54.71% |
| 2012-06-30 | GBX840.10K ≈ $102.22 |
-3.21% |
| 2011-06-30 | GBX868.00K ≈ $105.61 |
-5.86% |
| 2010-06-30 | GBX922.00K ≈ $112.18 |
+235.27% |
| 2009-06-30 | GBX275.00K ≈ $33.46 |
+141.23% |
| 2008-06-30 | GBX114.00K ≈ $13.87 |
-62.38% |
| 2007-06-30 | GBX303.00K ≈ $36.87 |
+107.53% |
| 2006-06-30 | GBX146.00K ≈ $17.76 |
-72.30% |
| 2005-06-30 | GBX527.00K ≈ $64.12 |
+466.67% |
| 2004-06-30 | GBX93.00K ≈ $11.32 |
+17.72% |
| 2003-06-30 | GBX79.00K ≈ $9.61 |
-43.17% |
| 2001-06-30 | GBX139.00K ≈ $16.91 |
-- |
About Physiomics Plc
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour pred… Read more